Seminars in Radiation Oncology
Volume 20, Issue 1 , Pages 21-29 , January 2010

Radiation-Related Treatment Effects Across the Age Spectrum: Differences and Similarities or What the Old and Young Can Learn from Each Other

  • Matthew J. Krasin, MD

      Affiliations

    • Division of Radiation Oncology, Department of Radiological Sciences, St Jude Children's Research Hospital, Memphis, TN
    • Corresponding Author InformationAddress reprint requests to Matthew J. Krasin, MD, St Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 220, Memphis, TN 38105-3678
    • ,
  • Louis S. Constine, MD

      Affiliations

    • Departments of Radiation Oncology and Pediatrics, University of Rochester Medical Center, Rochester, NY
    • ,
  • Debra L. Friedman, MD MS

      Affiliations

    • Division of Cancer Control and Prevention, Vanderbilt-Ingram Cancer Center, Nashville, TN
    • ,
  • Lawrence B. Marks, MD

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC

References 

  1. Moreno M, Aristu J, Ramos LI, et al. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer. Clin Transl Oncol. 2007;9:596–602
  2. Kocak Z, Evans ES, Zhou SM, et al. Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys. 2005;62:635–638
  3. Frankovich J, Donaldson SS, Lee Y, et al. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: Atopy predicts idiopathic diffuse lung injury syndromes. Biol Blood Marrow Transplant. 2001;7:49–57
  4. Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42:1–9
  5. Koh ES, Sun A, Tran TH, et al. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2006;66:223–228
  6. Krengli M, Sacco M, Loi G, et al. Pulmonary changes after radiotherapy for conservative treatment of breast cancer: A prospective study. Int J Radiat Oncol Biol Phys. 2008;70:1460–1467
  7. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323–329
  8. Martel MK, Ten Haken RK, Hazuka MB, et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys. 1994;28:575–581
  9. Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 2001;51:650–659
  10. Hua C, Hoth K, Kun LE, et al. Radiation pneumonitis of pediatric patients with sarcoma and Hodgkin's lymphoma: A DVH analysis (abstract). Int J Radiat Oncol Biol Phys. 2008;72:s494
  11. Hua C, Hoth K, Kun LE, et al. Are dosimetric guildlines of adult lung cancer for preventing radiation pneumonitis applicable to pediatric radiotherapy involving lungs?. (abstract) Med Phys. 2008;35:2912
  12. Marks LB. Dosimetric predictors of radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 2002;54:313–316
  13. Marks LB, Bentzen SM, Deasy JO, et al: Radiation dose volume effects in the lung. Int Radiat Oncol Biol Phys (in press)
  14. Schneider RA, Schultze J, Jensen JM, et al. 20 Years of experience in static intensity-modulated total-body irradiation and lung toxicity: Results in 257 consecutive patients. Strahlenther Onkol. 2007;183:545–551
  15. Kahan Z, Csenki M, Varga Z, et al. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;68:673–681
  16. Johansson S, Bjermer L, Franzen L, et al. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol. 1998;49:41–47
  17. Kong FM, Ao X, Wang L, et al. The use of blood biomarkers to predict radiation lung toxicity: A potential strategy to individualize thoracic radiation therapy. Cancer Control. 2008;15:140–150
  18. Zhao L, Sheldon K, Chen M, et al. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer. 2008;59:232–239
  19. Hartsell WF, Scott CB, Dundas GS, et al. Can serum markers be used to predict acute and late toxicity in patients with lung cancer?: Analysis of RTOG 91-03. Am J Clin Oncol. 2007;30:368–376
  20. Rube CE, Palm J, Erren M, et al. Cytokine plasma levels: Reliable predictors for radiation pneumonitis?. PLoS ONE. 2008;3:e2898
  21. Lind PA, Marks LB, Hollis D, et al. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys. 2002;54:340–347
  22. Hart JP, McCurdy MR, Ezhil M, et al. Radiation pneumonitis: Correlation of toxicity with pulmonary metabolic radiation response. Int J Radiat Oncol Biol Phys. 2008;71:967–971
  23. Yorke ED, Jackson A, Rosenzweig KE, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2002;54:329–339
  24. Le CT, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer. 1994;10(suppl 1):S239–S244
  25. Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer (A report from the childhood cancer survivor study). Cancer. 2002;95:2431–2441
  26. Oguz A, Tayfun T, Citak EC, et al. Long-term pulmonary function in survivors of childhood Hodgkin's disease and non-Hodgkin's lymphoma. Pediatr Blood Cancer. 2007;49:699–703
  27. Weiner DJ, Maity A, Carlson CA, et al. Pulmonary function abnormalities in children treated with whole lung irradiation. Pediatr Blood Cancer. 2006;46:222–227
  28. Borst GR, De JK, Belderbos JS, et al. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys. 2005;62:639–644
  29. Theuws JC, Seppenwoolde Y, Kwa SL, et al. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys. 2000;47:1201–1208
  30. Miller KL, Zhou SM, Barrier RC, et al. Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2003;56:611–615
  31. Ma J, Zhang J, Zhou S, et al. Regional lung density changes after radiation therapy for tumors in and around thorax. Int J Radiat Oncol Biol Phys. April 28, 2009;[Epub ahead of print]
  32. Fan M, Marks LB, Hollis D, et al. Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction. J Clin Oncol. 2001;19:543–550
  33. Fan M, Marks LB, Lind P, et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys. 2001;51:311–317
  34. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:318–328
  35. Regaud C. Sur la sensibilite du tissu osseux normal vis-a-vis des rayons X et gamma et sur la mecanisme de l'osteoradionecrose. CR Soc Biol (Paris). 1922;87:629–932
  36. Curi MM, Dib LL. Osteoradionecrosis of the jaws: A retrospective study of the background factors and treatment in 104 cases. J Oral Maxillofac Surg. 1997;55:540–544
  37. Cheon YW, Lee MC, Kim YS, et al. Gluteal artery perforator flap: A viable alternative for sacral radiation ulcer and osteoradionecrosis. J Plast Reconstr Aesthet Surg. April 2, 2009;[Epub ahead of print]
  38. Mendenhall WM. Mandibular osteoradionecrosis. J Clin Oncol. 2004;22:4867–4868
  39. Reuther T, Schuster T, Mende U, et al. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003;32:289–295
  40. Lee IJ, Koom WS, Lee CG, et al. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients. Int J Radiat Oncol Biol Phys. March 25, 2009;[Epub ahead of print]
  41. Teng MS, Futran ND. Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg. 2005;13:217–221
  42. Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg. 2004;62:527–534
  43. Studer G, Studer SP, Zwahlen RA, et al. Osteoradionecrosis of the mandible: Minimized risk profile following intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2006;182:283–288
  44. Annane D, Depondt J, Aubert P, et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: A randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol. 2004;22:4893–4900
  45. Indelicato DJ, Keole SR, Shahlaee AH, et al. Definitive radiotherapy for ewing tumors of extremities and pelvis: Long-term disease control, limb function, and treatment toxicity. Int J Radiat Oncol Biol Phys. 2008;72:871–877
  46. Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004;60:265–274
  47. Coletti D, Ord RA. Treatment rationale for pathological fractures of the mandible: A series of 44 fractures. Int J Oral Maxillofac Surg. 2008;37:215–222
  48. Engleman MA, Woloschak G, Small W. Radiation-induced skeletal injury. Cancer Treat Rev. 2006;128:155–169
  49. Lin PP, Schupak KD, Boland PJ, et al. Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma. Cancer. 1998;82:2356–2365
  50. Helmstedter CS, Goebel M, Zlotecki R, et al. Pathologic fractures after surgery and radiation for soft tissue tumors. Clin Orthop Relat Res. 2001;389:165–172
  51. Dickie CI, Parent AL, Griffin AM, et al. Bone fractures following external beam radiotherapy and limb-preservation Surgery for lower extremity soft tissue sarcoma: Relationship to irradiated bone length, volume, tumor location and dose. Int J Radiat Oncol Biol Phys. April 11, 2009;[Epub ahead of print]
  52. Probert JC, Parker BR. The effects of radiation therapy on bone growth. Radiology. 1975;114:155–162
  53. De Smet AA, Kuhns LR, Fayos JV, et al. Effects of radiation therapy on growing long bones. Am J Roentgenol. 1976;127:935–939
  54. Littman PS, D'Angio GJ. Growth considerations in the radiation therapy of children with cancer. Annu Rev Med. 1979;30:405–415
  55. Silber JH, Littman PS, Meadows AT. Stature loss following skeletal irradiation for childhood cancer. J Clin Oncol. 1990;8:304–312
  56. Willman KY, Cox RS, Donaldson SS. Radiation induced height impairment in pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1994;28:85–92
  57. Krasin MJ, Xiaoping X, Shengjie W, et al. The effects of external beam irradiation on the growth of flat bones in children: Modeling a dose-volume effect. Int J Radiat Oncol Biol Phys. 2005;62:1458–1462
  58. Eifel PJ, Donaldson SS, Thomas PR. Response of growing bone to irradiation: A proposed late effects scoring system. Int J Radiat Oncol Biol Phys. 1995;31:1301–1307
  59. Kaste SC, Chen G, Fontanesi J, et al. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol. 1997;15:1183–1189
  60. Merchant TE, Nguyen L, Nguyen D, et al. Differential attenuation of clavicle growth after asymmetric mantle radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:556–561
  61. Hartley KA, Li C, Laningham FH, et al. Vertebral body growth after craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2008;70:1343–1349
  62. Horton JA, Margulies BS, Strauss JA, et al. Restoration of growth plate function following radiotherapy is driven by increased proliferative and synthetic activity of expansions of chondrocytic clones. J Orthop Res. 2006;24:1945–1956
  63. Damron TA, Horton JA, Pritchard MR, et al. Histomorphometric evidence of growth plate recovery potential after fractionated radiotherapy: An in vivo model. Radiat Res. 2008;170:284–291
  64. Topkan E, Tufan H, Yavuz AA, et al. Comparison of the protective effects of melatonin and amifostine on radiation-induced epiphyseal injury. Int J Radiat Biol. 2008;84:796–802

 Supported in part by the American Lebanese Syrian Associated Charities (ALSAC) and the Lance Armstrong Foundation.

PII: S1053-4296(09)00063-0

doi: 10.1016/j.semradonc.2009.09.001

Seminars in Radiation Oncology
Volume 20, Issue 1 , Pages 21-29 , January 2010

Article Tools

* Image Usage & Resolution